Correlation Between Scpharmaceuticals and Dermata Therapeutics
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Dermata Therapeutics, you can compare the effects of market volatilities on Scpharmaceuticals and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Dermata Therapeutics.
Diversification Opportunities for Scpharmaceuticals and Dermata Therapeutics
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Scpharmaceuticals and Dermata is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Dermata Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Dermata Therapeutics go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Dermata Therapeutics
Given the investment horizon of 90 days Scpharmaceuticals is expected to generate 1.27 times more return on investment than Dermata Therapeutics. However, Scpharmaceuticals is 1.27 times more volatile than Dermata Therapeutics. It trades about -0.12 of its potential returns per unit of risk. Dermata Therapeutics is currently generating about -0.31 per unit of risk. If you would invest 437.00 in Scpharmaceuticals on August 29, 2024 and sell it today you would lose (63.00) from holding Scpharmaceuticals or give up 14.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Dermata Therapeutics
Performance |
| Timeline |
| Scpharmaceuticals |
| Dermata Therapeutics |
Scpharmaceuticals and Dermata Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Dermata Therapeutics
The main advantage of trading using opposite Scpharmaceuticals and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Dermata Therapeutics vs. Zura Bio Limited | Dermata Therapeutics vs. Phio Pharmaceuticals Corp | Dermata Therapeutics vs. Sonnet Biotherapeutics Holdings | Dermata Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |